Located near Exeter, PrognostiX-Poultry provides enhanced technology to bring together real-time data for poultry farmers to monitor overall health performance of the birds.
Merck Animal Health is a global biopharmaceutical company, operating in more than 150 countries.
The Corporate Commercial Team, having worked with this highly impressive start up on corporate and commercial matters for the past two years, advised the founders on all aspects of the deal.
The team was led by Evelyn Adfield, supported by Sara Townsend.
Evelyn Adfield commented:
“We are delighted to have worked with the PrognostiX-Poultry founders since the early days of this innovative business and to have played a part in achieving onward sale to Merck Animal Health. We look forward to seeing the continued growth and development of the business following this strategic transaction.”
Alan Beynon, CEO of PrognostiX-Poultry, commented:
“As a small start-up business, we were very appreciative and impressed by the total support offered by Evelyn and her team at Porter Dodson through a rigorous due diligence process with a large US based corporate.”